GemPharmatech Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -5.05% vs 8.47% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 44.04% vs -16.15% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "206.80",
          "val2": "217.80",
          "chgp": "-5.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "46.20",
          "val2": "59.00",
          "chgp": "-21.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.70",
          "val2": "1.50",
          "chgp": "13.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.50",
          "val2": "-1.40",
          "chgp": "135.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "47.10",
          "val2": "32.70",
          "chgp": "44.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "223.20%",
          "val2": "165.80%",
          "chgp": "5.74%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 15.41% vs 10.83% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 29.87% vs -30.90% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "792.40",
          "val2": "686.60",
          "chgp": "15.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "242.50",
          "val2": "188.40",
          "chgp": "28.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "6.40",
          "val2": "4.50",
          "chgp": "42.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.70",
          "val2": "2.30",
          "chgp": "-69.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "142.60",
          "val2": "109.80",
          "chgp": "29.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "191.30%",
          "val2": "133.30%",
          "chgp": "5.80%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

206.80

217.80

-5.05%

Operating Profit (PBDIT) excl Other Income

46.20

59.00

-21.69%

Interest

1.70

1.50

13.33%

Exceptional Items

0.50

-1.40

135.71%

Consolidate Net Profit

47.10

32.70

44.04%

Operating Profit Margin (Excl OI)

223.20%

165.80%

5.74%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -5.05% vs 8.47% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 44.04% vs -16.15% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

792.40

686.60

15.41%

Operating Profit (PBDIT) excl Other Income

242.50

188.40

28.72%

Interest

6.40

4.50

42.22%

Exceptional Items

0.70

2.30

-69.57%

Consolidate Net Profit

142.60

109.80

29.87%

Operating Profit Margin (Excl OI)

191.30%

133.30%

5.80%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 15.41% vs 10.83% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 29.87% vs -30.90% in Dec 2024

All Annual Results